Results 221 to 230 of about 110,403 (278)

3D transformer-based dose prediction in HDR brachytherapy for cervical cancer. [PDF]

BMC Cancer
Guo W, Jian W, Zhu L, Zhang B, He Q, Yang G, Wang X.   +6 more
europepmc   +1 more source

Screening strategy to identify Cas9 variants with higher HDR activity based on diphtheria toxin. [PDF]

J Biomed Sci
Matsumoto D, Kubota K, Sato Y, Kato-Inui T, Nigorikawa K, Miyaoka Y, Nomura W.   +6 more
europepmc   +1 more source

Efficient multi-kilobase knock-ins in mice and cell lines using CRISPR/Cas9 and rAAV donors with unbiased whole-genome characterization by LOCK-seq. [PDF]

Nucleic Acids Res
Sentmanat MF, Wang ZT, Kouranova E, Peters ST, Chan WC, Lin J, Miao Y, White JM, Wallace M, Cui X.   +9 more
europepmc   +1 more source

HDR, etc.

Pierre Kaser, 2015
openaire   +2 more sources

Efficient high-precision transgene knock-in by Recombinases (Redα/β)-enhanced DNA integration-CRISPR-Cas9 (RED-CRISPR). [PDF]

Nat Commun
Li W, Liu S, Fang X, Zou J, Jiang Q, Min X, Zhu X, Cao Y, Gao X, Han W, Azhar M, Xing X, Li F, Zhang Y, Liu H, Cheng L, Wang C, Bao J.   +17 more
europepmc   +1 more source

Repurposing clinically safe drugs for DNA repair pathway choice in CRISPR genome editing and synthetic lethality. [PDF]

Nat Commun
Macak D, Kanis P, Riesenberg S.
europepmc   +1 more source

HUH-tagged Cas9 as a platform for efficient ssODN-mediated knock-in via embryo and adult injection in insects. [PDF]

Commun Biol
Shirai Y, Kao JA, Kumar T, Matsuda N, Nakagawa R, Nureki O, Extavour CG, Daimon T.   +7 more
europepmc   +1 more source

Supportive Care for HDR Brachytherapy in Gynecological Cancer: A Single Center Experience. [PDF]

In Vivo
Meinecke D, Bruns F, Christiansen H, Steinkasserer L, Knöchelmann AC.   +4 more
europepmc   +1 more source